Protein Free Media

For many antibodies, used primarily as research tools in academic labs, upstream production using a serum supplemented media platform is ideal and whilst purification of these cultures might result in a small percentage of bovine immunoglobulin being co-purified as a contaminant, this is usually not an issue with subsequent utilisation.

As the BioServ client base has expanded to include early phase drug discovery and clinical diagnostic supply companies, we have advanced our upstream service provision to include cell line adaptation and subsequent scale up using regulatory compliant serum and protein free media. Whilst this process incurs additional cost, for many applications it also adds value by enhancing end point product purity and consistency.